store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZINC69391 (CysHHC10 acetate(1408311-03-4 free base)) 是 Rac1 的选择性抑制剂,具有抗增殖和抗转移作用。 ZINC69391 干扰 Rac1 与 Dock180 的相互作用,降低 Rac1-GTP 水平并诱导细胞凋亡。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 863 | 现货 | ||
5 mg | ¥ 2,110 | 现货 | ||
10 mg | ¥ 3,430 | 现货 | ||
25 mg | ¥ 5,580 | 现货 | ||
50 mg | ¥ 7,830 | 现货 | ||
100 mg | ¥ 10,500 | 现货 | ||
500 mg | ¥ 20,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,280 | 现货 |
产品描述 | ZINC69391 (CysHHC10 acetate(1408311-03-4 free base)) is a selective inhibitor of Rac1 with antiproliferative and antimetastatic effects. ZINC69391 interferes with the interaction of Rac1 with Dock180, reduces Rac1-GTP levels and induces apoptosis. |
体外活性 | In U-87 MG and LN229 cells, ZINC69391 (0-125 μM) reduces cell proliferation of human glioma cells. ZINC69391 (50-100 μM) triggers cell cycle arrest[1]. ZINC69391 inhibits the growth of U937, HL-60, KG1A, and Jurkat cells (IC50s = 41-54 μM). In HL-60, U937, and KG1A cell lines, ZINC69391 (50 μM) triggers an increase in apoptotic cells. In LN229 cells, ZINC69391 (50 and 100 μM) augments the enzymatic activity of caspase 3 and increases the percentage of cells in the sub-G0/G1 phase in a concentration-dependent manner[3]. |
体内活性 | In specific pathogen-free female BALB/c inbred mice (bearing F3II cells), ZINC69391 (25 mg/kg; i.p) impairs metastatic lung colonization and reduces by about 60% the formation of total metastatic lung colonies[2]. |
别名 | ZINC-69391, ZINC 69391, N'-(4,6-dimethylpyrimidin-2-yl)-N-[2-(trifluoromethyl)phenyl]guanidine, CysHHC10 acetate(1408311-03-4 free base) |
分子量 | 309.29 |
分子式 | C14H14F3N5 |
CAS No. | 303094-67-9 |
store at low temperature,keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (64.66 mM), Sonication and heating to 60℃ are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.2332 mL | 16.1661 mL | 32.3321 mL | 80.8303 mL |
5 mM | 0.6466 mL | 3.2332 mL | 6.4664 mL | 16.1661 mL | |
10 mM | 0.3233 mL | 1.6166 mL | 3.2332 mL | 8.083 mL | |
20 mM | 0.1617 mL | 0.8083 mL | 1.6166 mL | 4.0415 mL | |
50 mM | 0.0647 mL | 0.3233 mL | 0.6466 mL | 1.6166 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
ZINC69391 303094-67-9 Apoptosis Cell Cycle/Checkpoint Rho ZINC-69391 ZINC 69391 N'-(4,6-dimethylpyrimidin-2-yl)-N-[2-(trifluoromethyl)phenyl]guanidine CysHHC10 acetate(1408311-03-4 free base) Inhibitor inhibitor inhibit